Cargando…
Design, synthesis and evaluation of cytotoxic, antimicrobial, and anti-HIV-1 activities of new 1,2,3,4-tetrahydropyrimidine derivatives
A series of new 1,2,3,4-tetrahydropyrimidine (THPM) derivatives were designed and synthesized within a one-pot three component Biginelli reaction. The structures of compounds were characterized by FT-IR, 1HNMR, mass spectroscopy, and elemental analysis. All synthesized derivatives were screened for...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791171/ https://www.ncbi.nlm.nih.gov/pubmed/31620192 http://dx.doi.org/10.4103/1735-5362.253363 |
_version_ | 1783458931466567680 |
---|---|
author | Razzaghi-Asl, Nima Kamrani-Moghadam, Mahsa Farhangi, Behzad Vahabpour, Rouhollah Zabihollahi, Rezvan Sepehri, Saghi |
author_facet | Razzaghi-Asl, Nima Kamrani-Moghadam, Mahsa Farhangi, Behzad Vahabpour, Rouhollah Zabihollahi, Rezvan Sepehri, Saghi |
author_sort | Razzaghi-Asl, Nima |
collection | PubMed |
description | A series of new 1,2,3,4-tetrahydropyrimidine (THPM) derivatives were designed and synthesized within a one-pot three component Biginelli reaction. The structures of compounds were characterized by FT-IR, 1HNMR, mass spectroscopy, and elemental analysis. All synthesized derivatives were screened for their cytotoxic, antimicrobial, and anti-HIV activities. Due to significant cytotoxic and antimicrobial effects of 1,2,3,4-THPM scaffold, in this study, cytotoxic and antimicrobial activities of synthesized derivatives were evaluated on two cell lines and four bacterial strains. Compounds 4e and 4k showed highest cytotoxic activity against HeLa and MCF-7 cell lines. In addition, 4c and 4d were most active against MCF-7 and HeLa cell lines, respectively. Among the compounds, 4e revealed high antimicrobial activity against four strains. According to the results, 4e possessing m-bromophenyl group at C-4 position of THPM exhibited the highest cytotoxic and antimicrobial effects. Also, all the newly synthesized compounds were evaluated for their anti-HIV-1 assay. Compounds 4l and 4a indicated remarkable anti-HIV-1 activity. It is concluded from cytotoxic, antimicrobial, and anti-HIV-1 activities that the 1,2,3,4-tertahydropyrimidines may serve as hit compounds for development of new anticancer small-molecules. |
format | Online Article Text |
id | pubmed-6791171 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-67911712019-10-16 Design, synthesis and evaluation of cytotoxic, antimicrobial, and anti-HIV-1 activities of new 1,2,3,4-tetrahydropyrimidine derivatives Razzaghi-Asl, Nima Kamrani-Moghadam, Mahsa Farhangi, Behzad Vahabpour, Rouhollah Zabihollahi, Rezvan Sepehri, Saghi Res Pharm Sci Original Article A series of new 1,2,3,4-tetrahydropyrimidine (THPM) derivatives were designed and synthesized within a one-pot three component Biginelli reaction. The structures of compounds were characterized by FT-IR, 1HNMR, mass spectroscopy, and elemental analysis. All synthesized derivatives were screened for their cytotoxic, antimicrobial, and anti-HIV activities. Due to significant cytotoxic and antimicrobial effects of 1,2,3,4-THPM scaffold, in this study, cytotoxic and antimicrobial activities of synthesized derivatives were evaluated on two cell lines and four bacterial strains. Compounds 4e and 4k showed highest cytotoxic activity against HeLa and MCF-7 cell lines. In addition, 4c and 4d were most active against MCF-7 and HeLa cell lines, respectively. Among the compounds, 4e revealed high antimicrobial activity against four strains. According to the results, 4e possessing m-bromophenyl group at C-4 position of THPM exhibited the highest cytotoxic and antimicrobial effects. Also, all the newly synthesized compounds were evaluated for their anti-HIV-1 assay. Compounds 4l and 4a indicated remarkable anti-HIV-1 activity. It is concluded from cytotoxic, antimicrobial, and anti-HIV-1 activities that the 1,2,3,4-tertahydropyrimidines may serve as hit compounds for development of new anticancer small-molecules. Wolters Kluwer - Medknow 2019-03-08 /pmc/articles/PMC6791171/ /pubmed/31620192 http://dx.doi.org/10.4103/1735-5362.253363 Text en Copyright: © 2019 Research in Pharmaceutical Sciences http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Razzaghi-Asl, Nima Kamrani-Moghadam, Mahsa Farhangi, Behzad Vahabpour, Rouhollah Zabihollahi, Rezvan Sepehri, Saghi Design, synthesis and evaluation of cytotoxic, antimicrobial, and anti-HIV-1 activities of new 1,2,3,4-tetrahydropyrimidine derivatives |
title | Design, synthesis and evaluation of cytotoxic, antimicrobial, and anti-HIV-1 activities of new 1,2,3,4-tetrahydropyrimidine derivatives |
title_full | Design, synthesis and evaluation of cytotoxic, antimicrobial, and anti-HIV-1 activities of new 1,2,3,4-tetrahydropyrimidine derivatives |
title_fullStr | Design, synthesis and evaluation of cytotoxic, antimicrobial, and anti-HIV-1 activities of new 1,2,3,4-tetrahydropyrimidine derivatives |
title_full_unstemmed | Design, synthesis and evaluation of cytotoxic, antimicrobial, and anti-HIV-1 activities of new 1,2,3,4-tetrahydropyrimidine derivatives |
title_short | Design, synthesis and evaluation of cytotoxic, antimicrobial, and anti-HIV-1 activities of new 1,2,3,4-tetrahydropyrimidine derivatives |
title_sort | design, synthesis and evaluation of cytotoxic, antimicrobial, and anti-hiv-1 activities of new 1,2,3,4-tetrahydropyrimidine derivatives |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791171/ https://www.ncbi.nlm.nih.gov/pubmed/31620192 http://dx.doi.org/10.4103/1735-5362.253363 |
work_keys_str_mv | AT razzaghiaslnima designsynthesisandevaluationofcytotoxicantimicrobialandantihiv1activitiesofnew1234tetrahydropyrimidinederivatives AT kamranimoghadammahsa designsynthesisandevaluationofcytotoxicantimicrobialandantihiv1activitiesofnew1234tetrahydropyrimidinederivatives AT farhangibehzad designsynthesisandevaluationofcytotoxicantimicrobialandantihiv1activitiesofnew1234tetrahydropyrimidinederivatives AT vahabpourrouhollah designsynthesisandevaluationofcytotoxicantimicrobialandantihiv1activitiesofnew1234tetrahydropyrimidinederivatives AT zabihollahirezvan designsynthesisandevaluationofcytotoxicantimicrobialandantihiv1activitiesofnew1234tetrahydropyrimidinederivatives AT sepehrisaghi designsynthesisandevaluationofcytotoxicantimicrobialandantihiv1activitiesofnew1234tetrahydropyrimidinederivatives |